The addition of immunotherapy has shown improvement in distant recurrence. The results were discussed in Keynote-522 study. The study used pembrolizumab as the drug for immune therapy along with chemotherapy.
Immunotherapy and chemotherapy in Triple Negative Breast Cancer (TNBC) – New treatment before surgery
